Showing results (781-790 of 3,353) with videos related to

Sort By:
Pageof 336
The Lancet. Oncology|May 2, 2024
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer (TOPAZ-1): patient-reported outcomes from a randomised, double-blind, placebo-controlled, phase 3 trialHoward A Burris, Takuji Okusaka, Arndt Vogel, et al.
The Lancet. Oncology|May 31, 2024
Trends in nuclear medicine and the radiopharmaceutical sciences in oncology: workforce challenges and training in the age of theranosticsAndrew M Scott, Brian M Zeglis, Suzanne E Lapi, et al.
The Lancet. Oncology|May 31, 2024
Production and regulatory issues for theranosticsFrancesco Giammarile, Diana Paez, Richard Zimmermann, et al.
The Lancet. Oncology|May 31, 2024
Quantification of the environmental impact of radiotherapy and associated secondary human health effects: a multi-institutional retrospective analysis and simulationKatie E Lichter, Kiley Charbonneau, Jacqueline R Lewy, et al.
The Lancet. Oncology|May 16, 2024
Effect of Project Orbis participation by the Swiss regulator on submission gaps, review times, and drug approval decisions between 2020 and 2022: a comparative analysisMatea Zosso-Pavic, Qiyu Li, Eiman Atiek, et al.
The Lancet. Oncology|April 15, 2024
Changes in hospital mortality in patients with cancer during the COVID-19 pandemic (ISARIC-CCP-UK): a prospective, multicentre cohort studyLance Turtle, Sarah Elliot, Thomas M Drake, et al.
The Lancet. Oncology|December 8, 2025
Cancer mortality rates by detailed occupation among US working-age adults between 2020 and 2023: a population-based studyJacob D Lesinski, Jingbo Yi, Elizabeth Ghias, et al.
The Lancet. Oncology|November 23, 2025
Artificial intelligence and radiologists in pancreatic cancer detection using standard of care CT scans (PANORAMA): an international, paired, non-inferiority, confirmatory, observational studyNatalia Alves, Megan Schuurmans, Dawid Rutkowski, et al.
The Lancet. Oncology|November 27, 2025
Total neoadjuvant therapy followed by non-operative management or surgery in stage II-III rectal cancer (NO-CUT): a multicentre, single-arm, phase 2 trialAlessio Amatu, Giorgio Patelli, Maria Giulia Zampino, et al.
The Lancet. Oncology|November 27, 2025
A prognostic classification system for extent of resection in IDH-mutant grade 2 glioma: an international, multicentre, retrospective cohort study with external validation by the RANO resect groupPhilipp Karschnia, Jacob S Young, Maarten M J Wijnenga, et al.
Pageof 336